At the 2025 ASCRS meeting, Dr. Sarkisian presented 3-year data on the iDose TR from the FDA clinical trial.
Steven R. Sarkisian Jr., MD, ABO
Advertisement
Articles by Steven R. Sarkisian Jr., MD, ABO
Advertisement
Latest Updated Articles
Nitric Oxide and Its Important Role in the Trabecular Meshwork of Glaucoma PatientsPublished: December 21st 2018 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Positive pediatric data emerge from the OPGx-LCA5 phase 1/2 trial of Leber congenital amaurosis type 5
2
Q&A: Nadia Waheed on the role of OCT in the future of ophthalmology
3
Researchers assess atropine and cyclopentolate for detecting premyopia in young children
4
Q&A: Patricio Schlottmann discusses results of AVONELLE-X faricimab extension trial
5
.png "Optometry Times"){kind=logo}
